Wendy future of retail top

National Community Pharmacists Association

NCPA urges more scrutiny of generic drug pricing

NCPA urges more scrutiny of generic drug pricing

ALEXANDRIA, Va. — In tandem with a congressional hearing, the National Community Pharmacists Association called on lawmakers to take a closer look at recent generic drug price hikes and their impact on patients and community pharmacists. On Wednesday, the Senate Special Committee on Aging held a hearing titled “Sudden Price Spikes in Off-Patent Drugs: Perspectives

WBA-Rite Aid deal likely to draw scrutiny from regulators

DEERFIELD, Ill. — Walgreens Boots Alliance may have to divest up to 400 of the Rite Aid stores it is acquiring to satisfy antitrust regulations, analysts said. WBA is not publicly speculating on how many units it will have to shutter, said chief executive officer Stefano Pessina. “We have analyzed things very carefully,” he said

New public-private partnership taking aim at Rx abuse

WASHINGTON — President Obama highlighted the need to change prescribing practices for opioid medications, channel more resources for addiction treatment and facilitate access to naloxone, a drug that helps prevent overdose deaths. “More Americans now die every year from drug overdoses than they do from motor vehicle crashes. The majority of those overdoses involve legal

Senators urge close scrutiny of WBA-Rite Aid deal

Senators urge close scrutiny of WBA-Rite Aid deal

WASHINGTON — Two U.S. senators with oversight for antitrust issues have called on federal regulators to take a close look at Walgreens Boots Alliance Inc.’s $17.2 billion deal to acquire Rite Aid Corp. Sen. Mike Lee (R., Utah), chairman of the Senate Judiciary Subcommittee on Antitrust, Competition Policy and Consumer Rights, and Sen. Amy Klobuchar

Study: Appointment-based med sync gets results

Study: Appointment-based med sync gets results

ALEXANDRIA, Va. — Pharmacies offering appointment-based medication synchronization (ABMS) can improve patients’ adherence to their prescriptions and, in turn, produce better health outcomes, a study conducted for the National Community Pharmacists Association and Arkansas Pharmacists Association finds. NCPA said Monday that the one-year study, done by the University of Arkansas for Medical Sciences Department of

Workshop to explore quality ratings in Rx

The Pharmacy Quality Alliance (PQA) will co-host a one-day pharmacy quality ratings workshop with the American Pharmacists Association, the National Association of Chain Drug Stores, the National Community Pharmacists Association and the National Alliance of State Pharmacy Associations. The program will be held at the Westin Hotel in Old Town Alexandria, Va., on November 9.

Obama rallies public/private efforts vs. drug abuse

Obama rallies public/private efforts vs. drug abuse

WASHINGTON — The pharmacy industry is doing its part to help stem the tide of prescription drug abuse and heroin use as part of wide-ranging, public- and private-sector efforts announced this week by President Barack Obama. At a community forum in Charleston, W.Va., Obama and administration officials highlighted the need to change prescribing practices for

Industry stresses value of MTM

Industry stresses value of MTM

ARLINGTON, Va. — For a congressional hearing on medication therapy management, the National Association of Chain Drug Stores emphasized the value of pharmacists in providing MTM services, especially in improving medication adherence, patient health and health care affordability for Medicare patients. In a statement submitted Wednesday to the House Committee on Energy and Commerce Subcommittee

NCPA: Independent pharmacies holding their own

NCPA: Independent pharmacies holding their own

ALEXANDRIA, Va. — Independent community pharmacies are making strides in diversifying their revenue despite pressure from thinning prescription reimbursements and narrow pharmacy networks, according to the National Community Pharmacists Association. The 2015 NCPA Digest, released Tuesday and sponsored by Cardinal Health, shows how independent drug stores are serving up new pharmacy services — mainly focused

NCPA, HHS team up to drive enrollment

NATIONAL HARBOR, Md. — The National Community Pharmacists Association is working with U.S. Department of Health and Human Services (HHS) to help spur enrollment in health insurance plans. In a welcome video aired Monday at the 2015 NCPA Annual Convention and Trade Exposition, HHS Secretary Sylvia Burwell unveiled a partnership with NCPA in which community

Health Mart spotlights solutions at NCPA Annual Convention

Health Mart spotlights solutions at NCPA Annual Convention

WASHINGTON — McKesson Corp. and its Health Mart pharmacy franchise are showcasing solutions to help community pharmacies grow and fine-tune their business at the 117th Annual Convention and Trade Exposition of the National Community Pharmacists Association (NCPA). Health Mart said Friday that at the NCPA Annual Convention, which runs Oct. 10 to 14 in National

NCPA to roll out lab test platform for pharmacies

NCPA to roll out lab test platform for pharmacies

ALEXANDRIA, Va. — Community pharmacies will be able to offer patients direct access to lab tests and health screenings via a partnership announced by the National Community Pharmacists Association. NCPA said Friday that it will collaborate with consumer-direct lab testing provider Ulta Lab Tests LLC to roll out an online community lab testing platform to

Congress eyes health insurer consolidation

Congress eyes health insurer consolidation

Congressional scrutiny of the recent health insurer mega-mergers is a welcome sight, according to B. Douglas Hoey, CEO of the National Community Pharmacists Association. This summer, health insurer M&As reached a peak with Anthem’s $48 billion purchase of Cigna and Aetna’s $34 billion acquisition of Humana. On Thursday, the House Judiciary Committee’s Subcommittee on Regulatory

NCPA turns spotlight on underpayment for generics

NCPA turns spotlight on underpayment for generics

ALEXANDRIA, Va. — The National Community Pharmacists Association said it has compiled evidence that underscores the need for federal sunshine legislation to provide more insight into below-cost reimbursements from pharmacy benefit managers that don’t keep pace with rising market costs for generic drugs. NCPA said Monday that it recently asked members for examples illustrating the

PP_1170x120_10-25-21